✦ LIBER ✦

The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study

✍ Scribed by Maïté Lewin; Laetitia Fartoux; Alexandre Vignaud; Lionel Arrivé; Yves Menu; Olivier Rosmorduc

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AOSOP3 Combination of bevacizumab and er

✍ T. Yau; H. Wong; P. Chan; T.J. Yao; T.T. Cheung; S.T. Fan; R.T. Poon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Effects of the combined treatment with t

✍ F. Mirici Cappa; M.C. Cantarini; G. Magini; A. Zambruni; C. Bendini; V. Santi; M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 125 KB

High resolution in vivo characterization

✍ McLaughlin, Rebekah L.; Newitt, David C.; Wilmes, Lisa J.; Jones, Ella F.; Wisne 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB

4 SORAFENIB PLUS CISPLATIN AND GEMCITABI

✍ F. Giuliani; R. Addeo; A. Febbraio; D. Rizzi; E. Macello; S. del Prete; S. Pisco 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB